Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Current Data and Future Direction in LAAC
Video Series
Author(s):
Ricardo Boix-Garibo
,
Mohammed Mohsin Uzzaman
,
Vinayak Bapat
Added:
3 years ago
Aortic valve replacement via full sternotomy is the gold standard surgical therapy for patients with severe aortic stenosis (AS) and insufficiency.1 This procedure has proved to be reliable, reproducible, relieves symptoms and improves prognosis of the patients. Degenerative AS is the most frequently acquired valve disease in the elderly population. In the current era, aortic valve surgery is the…
View more
Author(s):
Basel Ramlawi
,
Mahesh Ramchandani
,
Michael J Reardon
Added:
3 years ago
Symptomatic severe aortic stenosis or insufficiency have no effective medical treatments and carry a dismal prognosis if left untreated. Since the first aortic valve replacement in 1960, hundreds of thousands of lives have been saved and improved by this procedure. Until recently, surgical aortic valve replacement (sAVR) was the only effective therapy for severe aortic valve stenosis. The recent…
View more
Author(s):
Pavel Overtchouk
,
Thomas Modine
Added:
3 years ago
This article aims to provide an updated comparative review, addressing the respective strengths and weaknesses of different alternative transcatheter aortic valve implantation (TAVI) approaches.
The transfemoral (TF) access is favoured by international guidelines on TAVI because of its reported superiority to the transthoracic approach.1–3 In spite of the progress in miniaturisation of new…
View more
Author(s):
Ole De Backer
Added:
1 year ago
In this interview, recorded at TCT 2022 in Boston (US), just afterthe results of PREDICT-LAA were presented,Prof Ole De Backer (Rigshospitalet, Copenhagen University Hospital, DK), the lead investigator of the trial,explains the core objectives of PREDICT-LAA and the key results that him and his investigators observed during this randomisedtrial.Watch the interview to discover PREDICT-LAA's…
View more
Author(s):
Dr Won-Keun Kim
Start date:
Oct 23, 2018
Transcatheter aortic valve implantation (TAVI) has emerged to be a viable treatment option for patients suffering from Severe Aortic Stenosis.
The transfemoral approach is the most common access route for TAVI and associated with most favourable clinical outcomes.
However, with a population with increasingly complex vasculature, the incidence of vascular complications in TAVI remains high…
View more
Ole De Backer
Job title: Interventional Cardiologist
Author
Author(s):
Ed Soltesz
Added:
1 year ago
Author(s):
Michael Lauterbach
,
Bruno Sontag
,
Karl-Eugen Hauptmann
Added:
3 years ago
Over the past nine years, since the first transcatheter aortic valve implantation (TAVI) by Cribier et al.1 in France in 2002, this new technique has enthralled cardiologists all over the world. With the deployment of TAVI – about 40,000 procedures have been carried out worldwide so far – cardiologists intruded into the previously unshared domain of surgical aortic valve replacement. Albeit…
View more